We describe two cases of fibrolamellar hepatocellular carcinoma of the liver in two young women. Both patients presented with diffuse intra-abdominal metastases; nevertheless they had a survival of 28 and 32 months, respectively, which sustains the better prognosis of this neoplasm. Electron microscopy of one case confirmed the oncocytic features of the neoplastic cells and showed intra- and intercellular duct-like vacuoles with numerous microvilli containing a microfilament core that terminated in a terminal web, which represents an unusual aspect in the spectrum of differentiation of fibrolamellar hepatocellular carcinoma.
BermanM.M., LibbeyN.P., FosterJ.H.: Hepatocellular carcinoma. Polygonal cell type with fibrous stroma. An atypical variant with a favorable prognosis.Cancer, 46: 1448–1455, 1980.
3.
BorelB., ChasleJ., RaffiP., RousselotP.: Le carcinome fibrolamellaire. A propos d'une observation.Arch. Anat. Cytol. Pathol., 30: 109–112, 1982 (Eng. Abstr.).
4.
CalleaF., MebisJ., DesmetV.J.: Myofibroblasts in focal nodular hyperplasia of the liver. Virchows. Arch. (Pathol.Anat.), 396: 155–166, 1982.
5.
ChouxR., PayanM.J., CharpinC., BoustiereC., OddouJ.H., LebreuilG.: Un nouveau cas de carcinome fibro-lamelaire du foie avec ultrastructure.Arch. Anat. Cytol. Pathol., 31: 283–286, 1983.
6.
CollierN.A., BloomS.R., HodgsonH.J.F., Wein-brenK., LeeY.C., BlumgartL.H.: Neurotensin secretion by fibrolamellar carcinoma of the liver.Lancet, 1: 583–540, 1984.
7.
CraigJ.R., PetersR.L., EdmondsonH.A., OmataM.: Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinicopathologic features.Cancer, 46: 372–379, 1980.
8.
EdmondsonH.A.: Differential diagnosis of tumors and tumor-like lesions of liver in infancy and childhood.Arch. Dis. Child., 1: 168–186, 1956.
OrdonezN.G., MacKayB.: Ultrastructure of liver cell and bile duct carcinoma.Ultrastruct. Pathol., 5: 201–241, 1983.
21.
ParadinasF.J., MeliaW.M., WilkinsonM.L., PortmannB., JohnsonP.J., Murray-LyonI.M., WilliamsR.: High serum vitamin B12 binding capacity as a marker of the fibrolamellar variant of hepatocellular carcinoma.Br. Med. J., 285: 840–842, 1982.
22.
PetersR.L.: Pathology of hepatocellular carcinoma. In: Hepatocellular Carcinoma.OkudaK., PetersR.L. (eds.), pp. 107–168, John Wiley & Sons, New York, 1976.
SheahanD.G.: Fibrolamellar carcinoma of the liver: an immunohistochemical study. Annual meeting abstracts. International Academy of Pathology. New Orleans, 1986.Lab. Invest., 54: 57, 1986.
25.
SlavutinL.J., DiamondN.: Case report. Hepatocellular carcinoma with lamellar fibrosis: an important histologic variant.Pathology, 13: 775–781, 1981.
26.
StarzlT.E., IwatsukiS., ShawB.W., NalesnikM.A., FarhiD.C., Van ThielD.H.: Treatment of fibrolamellar hepatoma with partial or total hepatectomy and transplantation of the liver.Surg. Gynecol. Obstet., 162: 145–148, 1986.
27.
StromeyerF.W., IshakK.G., GerberM.A., MathewT.: Ground-glass cells in hepatocellular carcinoma.Am. J. Clin. Pathol., 74: 254–158, 1980.
28.
TeitelbaumD.H., TuttleS., CareyL.C., ClausenK.P.: Fibrolamellar carcinoma of the liver. Review of three cases and the presentation of a characteristic set of tumor markers defining this tumor.Ann. Surg., 202: 36–41, 1985.
29.
VecchioF.M., FabianoA., GhirlandaG., MannaR., MassiG.: Fibrolamellar carcinoma of the liver: the malignant counterpart of focal nodular hyperplasia.Am. J. Clin. Pathol., 81: 521–526, 1984.
